Tomocube, Inc. (KOSDAQ:475960)

South Korea · Delayed Price · Currency is KRW

33,250

-1,250 (-3.62%)

At close: Oct 8, 2026

Market Cap	448.08B -35.6%
Revenue (ttm)	15.22B +123.6%
Net Income	-2.45B
EPS	-184.23
Shares Out	13.48M
PE Ratio	n/a
Forward PE	122.69
Dividend	n/a
Ex-Dividend Date	n/a

Volume	48,341
Open	33,950
Previous Close	34,500
Day's Range	33,200 - 35,550
52-Week Range	26,000 - 67,800
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Tomocube

Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibrat... [Read more]

Industry Laboratory Apparatus and Furniture

Founded 2015

Employees 66

Stock Exchange KOSDAQ

Ticker Symbol 475960

Full Company Profile

Financial Performance

In 2025, Tomocube's revenue was 11.31 billion, an increase of 90.39% compared to the previous year's 5.94 billion. Losses were -4.81 billion, -42.06% less than in 2024.

Financial Statements